We studied the effect of estrogen use on morbidity from cardiovascular disease in 1234 postmenopausal women, aged 50 to 83 years, participating in the Framingham Heart Study's 12th biennial examination (index examination). The medication history recorded at biennial examinations 8 through 12 was used to classify the degree of estrogen exposure before eight years of observation for cardiovascular morbidity and mortality. Despite a favorable cardiovascular risk profile and control for the major known risk factors for heart disease, women reporting postmenopausal estrogen use at one or more examinations had over a 50 per cent elevated risk of cardiovascular morbidity (P less than 0.01) and more than a twofold risk for cerebrovascular disease (P less than 0.01) after the index examination. Increased rates for myocardial infarction (P less than 0.05) were observed particularly among the estrogen users who smoked cigarettes. Conversely, among nonsmokers estrogen use was associated only with an increased incidence of stroke (P less than 0.05). No benefits from estrogen use were observed in the study group; in particular, mortality from all causes and from cardiovascular disease did not differ for estrogen users and nonusers.
This article has been cited by other articles:
Gass, M. L. S., Bassuk, S. S., Manson, J. E.
(2009). Reassessing Benefits and Risks of Hormone Therapy. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
3: 29-43
[Abstract]
Schulkin, J.
(2008). Hormone Therapy, Dilemmas, Medical Decisions.. J Law Med Ethics
36: 73-88
Rippe, J. M., Angelopoulos, T. J., Zukley, L.
(2007). The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
1: 10-19
[Abstract]
Bushnell, C. D., Hurn, P., Colton, C., Miller, V. M., del Zoppo, G., Elkind, M. S.V., Stern, B., Herrington, D., Ford-Lynch, G., Gorelick, P., James, A., Brown, C. M., Choi, E., Bray, P., Newby, L. K., Goldstein, L. B., Simpkins, J.
(2006). Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group. Stroke
37: 2387-2399
[Abstract][Full Text]
Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., Trevisan, M., Aragaki, A., Baird, A. E., Bray, P. F., Buring, J. E., Criqui, M. H., Herrington, D., Lynch, J. K., Rapp, S. R., Torner, J., for the WHI Investigators,
(2006). Effects of Conjugated Equine Estrogen on Stroke in the Women's Health Initiative. Circulation
113: 2425-2434
[Abstract][Full Text]
Shearman, A. M., Demissie, S., Cupples, L. A., Peter, I., Schmid, C. H., Ordovas, J. M., Mendelsohn, M. E., Housman, D. E.
(2005). Tobacco smoking, estrogen receptor {alpha} gene variation and small low density lipoprotein level. Hum Mol Genet
14: 2405-2413
[Abstract][Full Text]
Stampfer, M. J, Colditz, G. A
(2004). Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Int J Epidemiol
33: 445-453
[Full Text]
Canadian Task Force on Preventive Health Care,
(2004). Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease: Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ
170: 1388-1389
[Full Text]
Kannel, W. B., Levy, D.
(2004). Menopause, Hormones, and Cardiovascular Vulnerability in Women. Arch Intern Med
164: 479-481
[Full Text]
Col, N. F., Pauker, S. G.
(2003). The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy: Did Expectations Shape Experience?. ANN INTERN MED
139: 923-929
[Abstract][Full Text]
Kannel, W. B., Levy, D., Sullivan, J. L., Bailar, J. C. III
(2003). Hormone Therapy and Cardiovascular Disease. NEJM
349: 2075-2076
[Full Text]
Barrett-Connor, E.
(2003). An Epidemiologist Looks at Hormones and Heart Disease in Women. J. Clin. Endocrinol. Metab.
88: 4031-4042
[Full Text]
Bailar, J.
(2003). Hormone-Replacement Therapy and Cardiovascular Diseases. NEJM
349: 521-522
[Full Text]
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., Aragaki, A., Safford, M., Stein, E., Laowattana, S., Mysiw, W. J.
(2003). Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial. JAMA
289: 2673-2684
[Abstract][Full Text]
Lambert, L J, Straton, J A Y, Knuiman, M W, Bartholomew, H C
(2003). Health status of users of hormone replacement therapy by hysterectomy status in Western Australia. J. Epidemiol. Community Health
57: 294-300
[Abstract][Full Text]
Hurn, P. D., Brass, L. M.
(2003). Estrogen and Stroke: A Balanced Analysis. Stroke
34: 338-341
[Full Text]
Barlow, D. H.
(2003). Time to reflect on the Women's Health Initiative (WHI) Study. Hum Reprod
18: 1-3
[Full Text]
Lemaitre, R. N., Heckbert, S. R., Psaty, B. M., Smith, N. L., Kaplan, R. C., Longstreth, W. T. Jr
(2002). Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women. Arch Intern Med
162: 1954-1960
[Abstract][Full Text]
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., Allan, J. D.
(2002). Postmenopausal Hormone Replacement Therapy: Scientific Review. JAMA
288: 872-881
[Abstract][Full Text]
Humphrey, L. L., Chan, B. K.S., Sox, H. C.
(2002). Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease. ANN INTERN MED
137: 273-284
[Abstract][Full Text]
Hedblad, B., Merlo, J., Manjer, J., Engstrom, G., Berglund, G., Janzon, L.
(2002). Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy. Scand J Public Health
30: 12-19
[Abstract]
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., Horwitz, R. I.
(2001). A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke. NEJM
345: 1243-1249
[Abstract][Full Text]
Alexander, K. P., Newby, L. K., Hellkamp, A. S., Harrington, R. A., Peterson, E. D., Kopecky, S., Langer, A., O'Gara, P., O'Connor, C. M., Daly, R. N., Califf, R. M., Khan, S., Fuster, V.
(2001). Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol
38: 1-7
[Abstract][Full Text]
Worzala, K., Hiller, R., Sperduto, R. D., Mutalik, K., Murabito, J. M., Moskowitz, M., D'Agostino, R. B., Wilson, P. W. F.
(2001). Postmenopausal Estrogen Use, Type of Menopause, and Lens Opacities: The Framingham Studies. Arch Intern Med
161: 1448-1454
[Abstract][Full Text]
Bushnell, C. D., Samsa, G. P., Goldstein, L. B.
(2001). Hormone replacement therapy and ischemic stroke severity in women: A case-control study. Neurology
56: 1304-1307
[Abstract][Full Text]
Matthews, K. A., Kuller, L. H., Sutton-Tyrrell, K., Chang, Y.-F., Tietjen, G. E., Brey, R. L.
(2001). Changes in Cardiovascular Risk Factors During the Perimenopause and Postmenopause and Carotid Artery Atherosclerosis in Healthy Women Editorial Comment : Premenopausal Risk Continuum for Carotid Atherosclerosis After Menopause. Stroke
32: 1104-1111
[Abstract][Full Text]
Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., Hulley, S. B.
(2001). Postmenopausal Hormone Therapy and Risk of Stroke : The Heart and Estrogen-progestin Replacement Study (HERS). Circulation
103: 638-642
[Abstract][Full Text]
Otsuki, M., Saito, H., Xu, X., Sumitani, S., Kouhara, H., Kishimoto, T., Kasayama, S.
(2001). Progesterone, but Not Medroxyprogesterone, Inhibits Vascular Cell Adhesion Molecule-1 Expression in Human Vascular Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
21: 243-248
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J., Members,
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Circulation
103: 163-182
[Full Text]
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J.
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Stroke
32: 280-299
[Full Text]
Rossberg, M. I., Murphy, S. J., Traystman, R. J., Hurn, P. D., Kontos, H. A.
(2000). LY353381.HCl, a Selective Estrogen Receptor Modulator, and Experimental Stroke Editorial Comment. Stroke
31: 3041-3046
[Abstract][Full Text]
Edmunds, E., Landray, M., Lip, G. Y.H.
(2000). Hormone Replacement Therapy and Intima-Media Thickness of the Common Carotid Artery: The Rotterdam Study. Stroke
31
: i-2278
[Full Text]
Dubey, R. K., Jackson, E. K., Gillespie, D. G., Zacharia, L. C., Imthurn, B., Keller, P. J.
(2000). Clinically Used Estrogens Differentially Inhibit Human Aortic Smooth Muscle Cell Growth and Mitogen-Activated Protein Kinase Activity. Arterioscler. Thromb. Vasc. Bio.
20: 964-972
[Abstract][Full Text]
EDMUNDS, E., LIP, G.Y.H.
(2000). Cardiovascular risk in women: the cardiologist's perspective. QJM
93: 135-145
[Full Text]
Perry, H. M. III
(1999). The Endocrinology of Aging. Clin. Chem.
45: 1369-1376
[Abstract][Full Text]
Rusa, R., Alkayed, N. J., Crain, B. J., Traystman, R. J., Kimes, A. S., London, E. D., Klaus, J. A., Hurn, P. D., Iadecola, C.
(1999). 17{beta}-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals • Editorial Comment. Stroke
30: 1665-1670
[Abstract][Full Text]
Teede, H. J., Liang, Y.-L., Shiel, L. M., McNeil, J. J., McGrath, B. P.
(1999). Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function. J Am Coll Cardiol
34: 131-137
[Abstract][Full Text]
Bousser, M.-G.
(1999). Stroke in Women : The 1997 Paul Dudley White International Lecture. Circulation
99: 463-467
[Full Text]
Christ, M., Wehling, M.
(1998). Cardiovascular steroid actions: swift swallows or sluggish snails?. Cardiovasc Res
40: 34-44
[Abstract][Full Text]
Wilson, P. W. F., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., Kannel, W. B.
(1998). Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation
97: 1837-1847
[Abstract][Full Text]
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., Ockene, I. S., Pearson, T. A., Reed, J., Washington, R., Smith, S. C. Jr
(1998). Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction. Circulation
97: 1876-1887
[Full Text]
Sorensen, K. E., Dorup, I., Hermann, A. P., Mosekilde, L.
(1998). Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function. Circulation
97: 1234-1238
[Abstract][Full Text]
Biller, J., Feinberg, W. M., Castaldo, J. E., Whittemore, A. D., Harbaugh, R. E., Dempsey, R. J., Caplan, L. R., Kresowik, T. F., Matchar, D. B., Toole, J. F., Easton, J. D., Adams, H. P. Jr, Brass, L. M., Hobson, R. W. II, Brott, T. G., Sternau, L.
(1998). Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Circulation
97: 501-509
[Full Text]
Biller, J., Feinberg, W. M., Castaldo, J. E., Whittemore, A. D., Harbaugh, R. E., Dempsey, R. J., Caplan, L. R., Kresowik, T. F., Matchar, D. B., Toole, J. F., Easton, J. D., Adams, H. P. Jr, Brass, L. M., Hobson, R. W. II, Brott, T. G., Sternau, L.
(1998). Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke
29: 554-562
[Full Text]
Petitti, D. B., Sidney, S., Quesenberry, C. P. Jr, Bernstein, A.
(1998). Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy. Stroke
29: 23-28
[Abstract][Full Text]
Skafar, D. F., Xu, R., Morales, J., Ram, J., Sowers, J. R.
(1997). Female Sex Hormones and Cardiovascular Disease in Women. J. Clin. Endocrinol. Metab.
82: 3913-3918
[Abstract][Full Text]
Cauley, J. A., Seeley, D. G., Browner, W. S., Ensrud, K., Kuller, L. H., Lipschutz, R. C., Hulley, S. B.
(1997). Estrogen Replacement Therapy and Mortality Among Older Women: The Study of Osteoporotic Fractures. Arch Intern Med
157: 2181-2187
[Abstract]
Roberts, K. A., Woo, M. M., Rutledge, J. C.
(1997). Nitric Oxide Mediates LDL Uptake in the Artery Wall in Response to High Concentrations of 17ß-Estradiol. Arterioscler. Thromb. Vasc. Bio.
17: 2123-2131
[Abstract][Full Text]
McNagny, S. E., Jacobson, T. A.
(1997). Use of Postmenopausal Hormone Replacement Therapy by African American Women: The Importance of Physician Discussion. Arch Intern Med
157: 1337-1342
[Abstract]
Sullivan, J. M.
(1996). Estrogen Replacement. Circulation
94: 2699-2702
[Full Text]
Nabulsi, A. A., Folsom, A. R., Szklo, M., White, A., Higgins, M., Heiss, G.
(1996). No Association of Menopause and Hormone Replacement Therapy With Carotid Artery Intima-Media Thickness. Circulation
94: 1857-1863
[Abstract][Full Text]
Galatius-Jensen, S, Launbjerg, J, Mortensen, L S., Hansen, J F.
(1996). Sex related differences in short and long term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish verapamil infarction trial. BMJ
313: 137-140
[Abstract][Full Text]
Salamone, L. M., Pressman, A. R., Seeley, D. G., Cauley, J. A.
(1996). Estrogen Replacement Therapy: A Survey of Older Women's Attitudes. Arch Intern Med
156: 1293-1297
[Abstract]
Potshuma, W F M, Westendorp, R G J, Vandenbroucke, J P
(1994). Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?. BMJ
308: 1268-1269
[Abstract][Full Text]
Belchetz, P. E.
(1994). Hormonal Treatment of Postmenopausal Women. NEJM
330: 1062-1071
[Full Text]
Wild, R. A., Taylor, E. L., Knehans, A.
(1994). Review Article : The Gynecologist and Cardiovascular Disease: A Window of Opportunity for Prevention. Reproductive Sciences
1: 107-117
[Abstract]
Kuhn, F. E., Rackley, C. E.
(1993). Coronary Artery Disease in Women: Risk Factors, Evaluation, Treatment, and Prevention. Arch Intern Med
153: 2626-2636
[Abstract]
Psaty, B. M., Heckbert, S. R., Atkins, D., Siscovick, D. S., Koepsell, T. D., Wahl, P. W., Longstreth, W. T. Jr, Weiss, N. S., Wagner, E. H., Prentice, R., Furberg, C. D.
(1993). A Review of the Association of Estrogens and Progestins With Cardiovascular Disease in Postmenopausal Women. Arch Intern Med
153: 1421-1427
[Abstract]
Falkeborn, M., Persson, I., Terent, A., Adami, H.-O., Lithell, H., Bergstrom, R.
(1993). Hormone Replacement Therapy and the Risk of Stroke: Follow-up of a Population-Based Cohort in Sweden. Arch Intern Med
153: 1201-1209
[Abstract]
Finucane, F. F., Madans, J. H., Bush, T. L., Wolf, P. H., Kleinman, J. C.
(1993). Decreased Risk of Stroke Among Postmenopausal Hormone Users: Results From a National Cohort. Arch Intern Med
153: 73-79
[Abstract]
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., Cummings, S. R.
(1992). Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women. ANN INTERN MED
117: 1016-1037
[Abstract]
Reinhart, R. A., Broste, S. K., Arndt, M. R.
(1991). Gender and Lipids in Coronary Artery Disease-Reply. Arch Intern Med
151: 1881-1882
[Abstract]
Henderson, B. E., Paganini-Hill, A., Ross, R. K.
(1991). Decreased Mortality in Users of Estrogen Replacement Therapy. Arch Intern Med
151: 75-78
[Abstract]
Sullivan, J. M., Zwaag, R. V., Hughes, J. P., Maddock, V., Kroetz, F. W., Ramanathan, K. B., Mirvis, D. M.
(1990). Estrogen Replacement and Coronary Artery Disease: Effect on Survival in Postmenopausal Women. Arch Intern Med
150: 2557-2562
[Abstract]
Tosteson, A. N. A., Rosenthal, D. I., Melton, L. J. III, Weinstein, M. C.
(1990). Cost Effectiveness of Screening Perimenopausal White Women for Osteoporosis: Bone Densitometry and Hormone Replacement Therapy. ANN INTERN MED
113: 594-603
[Abstract]
Melton, L. J. III, Eddy, D. M., Johnston, C. C. Jr.
(1990). Screening for Osteoporosis. ANN INTERN MED
112: 516-528
[Abstract]
Resnick, N. M., Greenspan, S. L.
(1989). `Senile' Osteoporosis Reconsidered. JAMA
261: 1025-1029
[Abstract]
SULLIVAN, J. M., ZWAAG, R. V., LEMP, G. F., HUGHES, J. P., MADDOCK, V., KROETZ, F. W., RAMANATHAN, K. B., MIRVIS, D. M.
(1988). Postmenopausal Estrogen Use and Coronary Atherosclerosis. ANN INTERN MED
108: 358-363
[Abstract]
Riggs, B. L., Wahner, H. W.
(1988). Bone Densitometry and Clinical Decision-Making in Osteoporosis. ANN INTERN MED
108: 293-295
[Abstract]
Longstreth, W. T. Jr, Koepsell, T. D., van Belle, G.
(1987). Clinical Neuroepidemiology: II. Outcomes. Arch Neurol
44: 1196-1202
[Abstract]
CUMMINGS, S. R., BLACK, D.
(1986). Should Perimenopausal Women Be Screened for Osteoporosis?. ANN INTERN MED
104: 817-823
[Abstract]
Previous
